Targeting the CD47-SIRPA Axis in Oncology Analytical Tool 2020: 76 Drugs in Active Development in Cancer Across 28 Different Targets
- Tuesday, December 15, 2020, 7:00
- Finance
- Add a comment
DUBLIN, Dec. 15, 2020 /PRNewswire/ — The “Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool” report has been added to ResearchAndMarkets.com’s offering. Targeting the CD47-SIRPa axis is emerging as one of the most promising new cancer immunotherapy approaches seeking to target…
About the Author
adminasapcorp has written 41779 stories on this site.